Yan Weng
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Molecular Biology top 5%
- Fibroblast Growth Factor Research
- Kruppel-like factors research
- Epigenetics and DNA Methylation
- RNA Interference and Gene Delivery
Papers in
-
- Natural product bioactivities and synthesis 5
- Fibroblast Growth Factor Research 5
- Kruppel-like factors research 4
- Oncology 10
- Drug Transport and Resistance Mechanisms 9
- Co-authors
- Xinxin Ding (9 shared papers)Aidong Wen (18 shared papers)Jialin Duan (16 shared papers)Chao Guo (14 shared papers)Roberto A. Calle (5 shared papers)Jia Cui (11 shared papers)Melissa Behr (4 shared papers)J Chabot (3 shared papers)
- Journals
- Drug Metabolism and Disposition (4 papers)European Journal of Lipid Science and Technology (4 papers)Cancer Research (3 papers)Eye (3 papers)Journal of Ethnopharmacology (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yan Weng
84 papers receiving 2.8k citations
Yan Weng's Hit Papers
Peers
Comparison fields: 5 of 113
- Pharmacology 456
- Molecular Biology 1.3k
- Pharmaceutical Science 115
- Complementary and alternative medicine 124
- Biochemistry 112
Countries citing papers authored by Yan Weng
This map shows the geographic impact of Yan Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Weng more than expected).
Fields of papers citing papers by Yan Weng
This network shows the impact of papers produced by Yan Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Weng. The network helps show where Yan Weng may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Weng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects Hit paper breakdown → | 2016 | 415 |
| 2 | 2003 | 183 | |
| 3 | 2019 | 168 | |
| 4 | 2017 | 120 | |
| 5 | 2017 | 114 | |
| 6 | 2012 | 97 | |
| 7 | 2007 | 79 | |
| 8 | 2014 | 76 | |
| 9 | 2005 | 70 | |
| 10 | 2005 | 65 | |
| 11 | 1993 | 63 | |
| 12 | 2015 | 60 | |
| 13 | 2013 | 59 | |
| 14 | 2003 | 59 | |
| 15 | 2012 | 57 | |
| 16 | 2004 | 56 | |
| 17 | 2010 | 54 | |
| 18 | 2011 | 52 | |
| 19 | 2018 | 52 | |
| 20 | 2013 | 48 |
About Yan Weng
Yan Weng is a scholar working on Molecular Biology, Oncology, Pharmacology, Physiology and Surgery, having authored 86 papers that have together received 2.9k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Pharmacogenetics and Drug Metabolism (9 papers), Drug Solubulity and Delivery Systems (5 papers), Natural product bioactivities and synthesis (5 papers), Fibroblast Growth Factor Research (5 papers), Orthopaedic implants and arthroplasty (5 papers), Kruppel-like factors research (4 papers) and Traditional Chinese Medicine Analysis (4 papers). The work is most often cited by research in Pharmacology (456 citations), Molecular Biology (1.3k citations), Pharmaceutical Science (115 citations), Complementary and alternative medicine (124 citations) and Biochemistry (112 citations). Yan Weng has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xinxin Ding, Aidong Wen, Jialin Duan, Chao Guo, Roberto A. Calle, Jia Cui, Melissa Behr, J Chabot, Saswata Talukdar and Miaomiao Xi. Their work appears in journals such as Drug Metabolism and Disposition, European Journal of Lipid Science and Technology, Cancer Research, Eye and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.